Updated Guidelines on Handling of Specimens for Tuberculosis Testing (Xpert MTB/Rif Assay and Smear Microscopy) in the Presence of the Coronavirus Disease (COVID 19) Community Transmission 15 June 2020
Reiteration of the Guidelines on Proper Management of Patients Started on Drug-Resistant TB (DR-TB) Treatment Experiencing Hepatotoxicity, Myelosuppression, Peripheral Neuropathy, and QTe Prolongation 5 June 2020
Agreement during the Q 1 2020 National Consultation and Planning for the National TB Control Program held at Angeles City and Iloilo City on February 17-19 and March 9-11. 7 May 2020
Designation of Selected Regional TB Culture Laboratories for GeneXpert Diagnosis of Coronavirus Disease 2019 (COVID-19) 21 April 2020
Guidelines for Culture Laboratories on the Conduct of Mycobacteriological Tests under the Programmatic Management of Drug-resistant Tuberculosis 8 April 2020
Reiteration of Policy on the Implementation of Active TB drug-safety monitoring and management (aDSM) 18 March 2020
